Overview

Thromboprophylaxis and Bariatric Surgery

Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
0
Participant gender:
All
Summary
This trial is an assessment of the efficacy of three thromboprophylaxis regimens in two types of bariatric surgery. - gastric banding and gastric bypass on anti-Xa activity levels The study includes two groups of 150 patients scheduled for gastric banding or gastric bypass. Assessment of anti-Xa levels before and 4 hours after the injections from day 0 to 2 in order to determine the best prophylactic regimen allowing expected values ranged between 0.3 and 0.5 IU / ml.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital, Strasbourg, France
Collaborators:
French State
Sanofi
Treatments:
Enoxaparin
Criteria
Inclusion Criteria:

- BMI over 40

- Gastric banding or gastric bypass

Exclusion Criteria:

- Renal insufficiency

- Thrombopenia

- Long term anticoagulant treatment

- Pregnancy

- Allergy to heparin